Amneal named Generics bulletin’s Company of the Year

BRIDGEWATER, N.J. — Amneal Pharmaceuticals was named Company of the Year by Generics bulletin at this year’s Global Generics and Biosimilars Awards. This is the second year in a row that the industry newsletter has honored Amneal.

 

“Amneal prides itself in staying true to its core values: integrity, accountability, hard work, and collaboration,” Amneal co-CEO and chairman Chirag Patel said. “Winning this award is proof that acting on our values and executing our growth strategy has enabled us to continue to deliver on our promise of providing high-quality, affordable medicines for patients around the world.”

 

Amneal is the United States’ seventh largest generics manufacture by prescriptions.. The company’s annual sales are nearly $1 billion and it now has more than 86 FDA-approved molecules in its portfolio.